Inappropriate therapy for MRSA costly, potentially deadly, problem
- 期刊名称PharmacoEconomics & Outcomes News
- 卷第561卷
- 期第1期
- 印刷ISSN1173-5503
- 电子ISSN1179-2043
- 文件大小138.61KB
- 发表时间2008-09
- DOI10.2165/00151234-200805610-00006
同期刊推荐
Aztreonam tops tobramycin in CFPharmacoEconomics & Outcomes News · 2012
Warfarin prophylaxis justified in nonvalvular AFPharmacoEconomics & Outcomes News · 1998
Antiretrovirals in HIV infectionPharmacoEconomics & Outcomes News · 1999
Fidaxomicin value for money&NA; · PharmacoEconomics & Outcomes News · 2012
Diclofenac&NA; · PharmacoEconomics & Outcomes News · 2006
SMC accepts use of IluvienFarash, Mohammad Sabzinejad; Attari, Mahmoud Ahmadian · PharmacoEconomics & Outcomes News · 2014
Getting value from health insurance plansPharmacoEconomics & Outcomes News · 2014
Screening and decolonisation ofS.PharmacoEconomics & Outcomes News · 2014